CHEMBL3086852
Ligand Summary
Name: (3S,6S,9S,12S,15S,18S,21S,27S,30S,33S,36S,39S)-39-((6S,12S,15S,18S,21S,24S,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-12-(4-aminobutyl)-27-sec-butyl-6-carbamoyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-ylcarbamoyl)-27-(3-amino-3-oxopropyl)-3-((2S,5S,8S,11S,20S,23S)-23-amino-8-benzyl-17-tert-butyl-5,11-bis((R)-1-hydroxyethyl)-2-(hydroxymethyl)-24-(1H-imidazol-4-yl)-20-methyl-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazatetracosanamido)-36-(4-aminobutyl)-21-(2-carboxyethyl)-15-(4-hydroxybenzyl)-9,12-bis(hydroxymethyl)-18-isobutyl-6-isopropyl-30,33-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxo-5,8,11,14,17,20,23,26,29,32,35,38-dodecaazadotetracontane-1,42-dioic acid
PubChem: 91898597
ChEMBL: CHEMBL3086852
LyCHI: FFWA4HT1ZGU4
Target Activities
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
EC50 | ||||||
IC50 | ||||||